Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Grows By 64.6%

Biomerica, Inc. (NASDAQ:BMRA) was the target of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 419,000 shares, a growth of 64.6% from the January 31st total of 254,500 shares. Based on an average daily trading volume, of 7,750,000 shares, the short-interest ratio is presently 0.1 days.

Institutional Investors Weigh In On Biomerica

A hedge fund recently raised its stake in Biomerica stock. Granahan Investment Management LLC raised its stake in shares of Biomerica, Inc. (NASDAQ:BMRA) by 24.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 658,767 shares of the company’s stock after purchasing an additional 131,306 shares during the quarter. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 22.28% of the company’s stock.

Biomerica Stock Performance

NASDAQ BMRA opened at $0.73 on Friday. Biomerica has a 52-week low of $0.24 and a 52-week high of $1.27. The company has a 50-day simple moving average of $0.55 and a 200 day simple moving average of $0.42. The company has a market capitalization of $13.48 million, a PE ratio of -2.16 and a beta of -0.98.

Biomerica (NASDAQ:BMRA) last issued its earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.